You are viewing a free limited preview of Metagenomix, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

Metagenomix, Inc.

Private Company Ticker Symbol™: (METAGP)

Business Summary

Metagenomix, Inc. is a privately-held, venture capital backed biotechnology company that specializes in molecular biology and screening methods. Metagenomix, Inc. was founded in 2010 and is headquartered in Branford, Connecticut.

Overview & Corporate Organization

Basic Information

Company Tags:VC Backed
Year Founded:2010
Fiscal Year End:12/31
City:Branford
State/Province:Connecticut
Country:United States

Industry Information

Industry Codes

PICS™:1500110
NAICS:View
SIC:View

PrivCo Industries (Sector > Industry > Sub-Industry)

Technology > Biotechnology > Genomics And Molecular Analysis

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

VC/Funding Activity

PrivCo's VC/Funding Activity table for Metagenomix, Inc. displays the venture capital rounds, angel investments, debt or other funding raised by Metagenomix, Inc..
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateInvestorRoundInvestor Type
Apr. 2010ViewAVenture Capital
Apr. 2010ViewAVenture Capital
Apr. 2010ViewA
DetailsTotal Round A View
Aug. 2010ViewBVenture Capital
Aug. 2010ViewBVenture Capital
DetailsTotal Round B View
Total of Funding Shown Above View

Missing a deal? Tell us about it! tips@privco.com


You are viewing a free limited preview of Metagenomix, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access